Cargando…
CDH1 Testing: Can it Predict the Prophylactic or Therapeutic Nature of Total Gastrectomy in Hereditary Diffuse Gastric Cancer?
Autores principales: | Ziogas, Dimosthenis, Roukos, Dimitrios H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749437/ https://www.ncbi.nlm.nih.gov/pubmed/19636637 http://dx.doi.org/10.1245/s10434-009-0598-y |
Ejemplares similares
-
Targeting Gastric Cancer with Trastuzumab: New Clinical Practice and Innovative Developments to Overcome Resistance
por: Roukos, Dimitrios H.
Publicado: (2009) -
Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer
por: Shepard, Benjamin, et al.
Publicado: (2016) -
More Controversy than Ever – Challenges and Promises Towards Personalized Treatment of Gastric Cancer
por: Liakakos, Theodore, et al.
Publicado: (2008) -
Prophylactic Laparoscopic-Assisted Total Gastrectomy for Hereditary Diffuse Gastric Cancer
por: Francis, Wesley P., et al.
Publicado: (2007) -
Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series
por: Gjyshi, Olsi, et al.
Publicado: (2018)